Clinical Trials Logo
  1. Home
  2. Sugammadex
  3. NCT04608682

Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording

Sugammadex Clinical Trial

Official title:
Effect of Intraoperative Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording

Clinical Trial Summary

Transcranial motor evoked potential (TcMEP) monitoring is conventionally performed during surgery without or with minimal neuromuscular blockade (NMB) because of its potential interference with signal interpretation.The feasibility of TcMEP interpretation was assessed during partial NMB in adult neurosurgical patients. However, partial NMB may interfere record of TcMEP monitoring. Sugammadex is the first highly selective antagonist that can reverse NMB. This study aims to evaluate the success rate of intraoperative muscle relax reversal by sugammadex on intraoperative TceMEP recording.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04608682
Study type Interventional
Source Beijing Tiantan Hospital
Contact
Status Completed
Phase N/A
Start date August 16, 2021
Completion date August 30, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04997759 - Comparative Efficacy and Safety of Sugammadex and Neostigmine N/A
Recruiting NCT05794503 - Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Early Phase 1
Not yet recruiting NCT05751603 - Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex N/A
Completed NCT05066035 - Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine Phase 4
Active, not recruiting NCT06081738 - Neostigmine Versus Sugammadex on Renal Functions Phase 4
Completed NCT04471376 - The Effect of Sugammadex During Transcranial Electrical Motor Evoked Potential Monitoring in Spinal Surgery N/A
Recruiting NCT05028088 - Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex Phase 4
Recruiting NCT05886218 - Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
Completed NCT04332627 - Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine Phase 4
Recruiting NCT04566796 - Effectiveness of Sugammadex on Muscle Relaxant Reversal in Preterm Neonates N/A